Healthcare Triangle, Inc. Enabling healthcare and life sciences enterprises to implement virtual and augmented environment for patients and clinical trials PLEASANTON, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the “Company”) announces its offering and services towards enabling healthcare and life sciences enterprises to […]
Interactions
Prescription Drug Information, Interactions & Side Effects
Posted today in New Drug Approvals June 29, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination (FDC) of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with hyaluronidase, administered by subcutaneous […]